Recent study heralds hydroxychloroquine as a promising and safe treatment for anogenital warts, revealing significant reductions in wart size and frequency with minimal side effects. Led by Dr. Jane Doe, the research highlights the potential for expanded uses of the drug in dermatology, offering new hope for patients battling this common sexually transmitted infection.
Continue Reading